Literature DB >> 32234473

Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30.

Dario Rizzotto1, Sara Zaccara1, Annalisa Rossi1, Matthew D Galbraith2, Zdenek Andrysik2, Ahwan Pandey2, Kelly D Sullivan2, Alessandro Quattrone1, Joaquín M Espinosa2, Erik Dassi3, Alberto Inga4.   

Abstract

Activation of p53 by the small molecule Nutlin can result in a combination of cell cycle arrest and apoptosis. The relative strength of these events is difficult to predict by classical gene expression analysis, leaving uncertainty as to the therapeutic benefits. In this study, we report a translational control mechanism shaping p53-dependent apoptosis. Using polysome profiling, we establish Nutlin-induced apoptosis to associate with the enhanced translation of mRNAs carrying multiple copies of an identified 3' UTR CG-rich motif mediating p53-dependent death (CGPD-motif). We identify PCBP2 and DHX30 as CGPD-motif interactors. We find that in cells undergoing persistent cell cycle arrest in response to Nutlin, CGPD-motif mRNAs are repressed by the PCBP2-dependent binding of DHX30 to the motif. Upon DHX30 depletion in these cells, the translation of CGPD-motif mRNAs increases, and the response to Nutlin shifts toward apoptosis. Instead, DHX30 inducible overexpression in SJSA1 cells leads to decreased translation of CGPD-motif mRNAs.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3′ UTR; DHX30; Nutlin; PCBP2; apoptosis; p53; polysomal profiling; transcription; translation; translatome

Year:  2020        PMID: 32234473      PMCID: PMC7182397          DOI: 10.1016/j.celrep.2020.03.011

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  80 in total

1.  Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs.

Authors:  Ashish Lal; Krystyna Mazan-Mamczarz; Tomoko Kawai; Xiaoling Yang; Jennifer L Martindale; Myriam Gorospe
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 2.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

3.  mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end.

Authors:  D H Ostareck; A Ostareck-Lederer; M Wilm; B J Thiele; M Mann; M W Hentze
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

4.  A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response.

Authors:  Maite Huarte; Mitchell Guttman; David Feldser; Manuel Garber; Magdalena J Koziol; Daniela Kenzelmann-Broz; Ahmad M Khalil; Or Zuk; Ido Amit; Michal Rabani; Laura D Attardi; Aviv Regev; Eric S Lander; Tyler Jacks; John L Rinn
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

5.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

6.  The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30.

Authors:  Yongdong Zhou; Jing Ma; Bibhuti Bushan Roy; Jenny Yang-Yang Wu; Qinghua Pan; Liwei Rong; Chen Liang
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

7.  A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.

Authors:  M Kracikova; G Akiri; A George; R Sachidanandam; S A Aaronson
Journal:  Cell Death Differ       Date:  2013-01-11       Impact factor: 15.828

8.  The Mammalian Ribo-interactome Reveals Ribosome Functional Diversity and Heterogeneity.

Authors:  Deniz Simsek; Gerald C Tiu; Ryan A Flynn; Gun W Byeon; Kathrin Leppek; Adele F Xu; Howard Y Chang; Maria Barna
Journal:  Cell       Date:  2017-06-01       Impact factor: 41.582

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  Hyper conserved elements in vertebrate mRNA 3'-UTRs reveal a translational network of RNA-binding proteins controlled by HuR.

Authors:  Erik Dassi; Paola Zuccotti; Sara Leo; Alessandro Provenzani; Michael Assfalg; Mariapina D'Onofrio; Paola Riva; Alessandro Quattrone
Journal:  Nucleic Acids Res       Date:  2013-02-01       Impact factor: 16.971

View more
  10 in total

Review 1.  Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer.

Authors:  Jingyue Yan; Diana D Kang; Gillian Turnbull; Yizhou Dong
Journal:  Adv Drug Deliv Rev       Date:  2021-11-09       Impact factor: 15.470

Review 2.  RNA Helicases in Microsatellite Repeat Expansion Disorders and Neurodegeneration.

Authors:  Lydia M Castelli; Bridget C Benson; Wan-Ping Huang; Ya-Hui Lin; Guillaume M Hautbergue
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

3.  TranSNPs: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance.

Authors:  Samuel Valentini; Caterina Marchioretti; Alessandra Bisio; Annalisa Rossi; Sara Zaccara; Alessandro Romanel; Alberto Inga
Journal:  iScience       Date:  2021-11-27

4.  SRSF protein kinase 1 modulates RAN translation and suppresses CGG repeat toxicity.

Authors:  Yi-Ju Tseng; Shannon E Wright; Indranil Malik; Kristina Zheng; Prithika Ramaiyer; Katelyn M Green; Peter K Todd
Journal:  EMBO Mol Med       Date:  2021-09-20       Impact factor: 12.137

5.  Preferential translation of p53 target genes.

Authors:  Miharu Hisaoka; Johanna Schott; Toman Bortecen; Doris Lindner; Jeroen Krijgsveld; Georg Stoecklin
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

Review 6.  Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Authors:  Lucia Haronikova; Ondrej Bonczek; Pavlina Zatloukalova; Filip Kokas-Zavadil; Martina Kucerikova; Philip J Coates; Robin Fahraeus; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2021-12-15       Impact factor: 5.787

7.  Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency.

Authors:  Marta Rigoli; Giovanni Spagnolli; Giulia Lorengo; Paola Monti; Raffaello Potestio; Emiliano Biasini; Alberto Inga
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

8.  Conformational change of RNA-helicase DHX30 by ALS/FTD-linked FUS induces mitochondrial dysfunction and cytosolic aggregates.

Authors:  Ryota Hikiami; Toshifumi Morimura; Takashi Ayaki; Tomoyuki Tsukiyama; Naoko Morimura; Makiko Kusui; Hideki Wada; Sumio Minamiyama; Akemi Shodai; Megumi Asada-Utsugi; Shin-Ichi Muramatsu; Takatoshi Ueki; Ryosuke Takahashi; Makoto Urushitani
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

9.  A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.

Authors:  Muhammad Sohail; Lulzim Shkreta; Johanne Toutant; Safwat Rabea; Jean-Philippe Babeu; Caroline Huard; Jasmin Coulombe-Huntington; Aurélie Delannoy; Morgane Placet; Sameh Geha; Fernand-Pierre Gendron; François Boudreau; Mike Tyers; David S Grierson; Benoit Chabot
Journal:  NAR Cancer       Date:  2021-05-25

10.  Poly(C)-binding Protein 2 Regulates the p53 Expression via Interactions with the 5'-Terminal Region of p53 mRNA.

Authors:  Damian M Janecki; Agata Swiatkowska; Joanna Szpotkowska; Anna Urbanowicz; Martyna Kabacińska; Kamil Szpotkowski; Jerzy Ciesiołka
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.